Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in enterobacter cloacae complex following exposure to cefepime

Ryan K. Shields; Alina Iovleva; Ellen G. Kline; Akito Kawai; Christi L. McElheny; Yohei Doi

doi:10.1093/cid/ciaa355

Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in enterobacter cloacae complex following exposure to cefepime

Ryan K. Shields
, Alina Iovleva
, Ellen G. Kline
, Akito Kawai
, Christi L. McElheny
, Yohei Doi

Research output: Contribution to journal › Article › peer-review

85 Citations (Scopus)

Abstract

We report 2 independent patients from whom carbapenem and ceftazidime-avibactam–resistant Enterobacter cloacae complex strains were identified. The ceftazidime-avibactam resistance was attributed to a 2–amino acid deletion in the R2 loop of AmpC β-lactamase, which concurrently caused resistance to cefepime and reduced susceptibility to cefiderocol, a novel siderophore cephalosporin.

Original language	English
Pages (from-to)	2713-2716
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	71
Issue number	10
DOIs	https://doi.org/10.1093/cid/ciaa355
Publication status	Published - 15-11-2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciaa355

Cite this

@article{80d8864eba054c8db3ae7062d019d7c9,

title = "Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in enterobacter cloacae complex following exposure to cefepime",

abstract = "We report 2 independent patients from whom carbapenem and ceftazidime-avibactam–resistant Enterobacter cloacae complex strains were identified. The ceftazidime-avibactam resistance was attributed to a 2–amino acid deletion in the R2 loop of AmpC β-lactamase, which concurrently caused resistance to cefepime and reduced susceptibility to cefiderocol, a novel siderophore cephalosporin.",

author = "Shields, \{Ryan K.\} and Alina Iovleva and Kline, \{Ellen G.\} and Akito Kawai and McElheny, \{Christi L.\} and Yohei Doi",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2020.",

year = "2020",

month = nov,

day = "15",

doi = "10.1093/cid/ciaa355",

language = "English",

volume = "71",

pages = "2713--2716",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in enterobacter cloacae complex following exposure to cefepime

AU - Shields, Ryan K.

AU - Iovleva, Alina

AU - Kline, Ellen G.

AU - Kawai, Akito

AU - McElheny, Christi L.

AU - Doi, Yohei

PY - 2020/11/15

Y1 - 2020/11/15

N2 - We report 2 independent patients from whom carbapenem and ceftazidime-avibactam–resistant Enterobacter cloacae complex strains were identified. The ceftazidime-avibactam resistance was attributed to a 2–amino acid deletion in the R2 loop of AmpC β-lactamase, which concurrently caused resistance to cefepime and reduced susceptibility to cefiderocol, a novel siderophore cephalosporin.

AB - We report 2 independent patients from whom carbapenem and ceftazidime-avibactam–resistant Enterobacter cloacae complex strains were identified. The ceftazidime-avibactam resistance was attributed to a 2–amino acid deletion in the R2 loop of AmpC β-lactamase, which concurrently caused resistance to cefepime and reduced susceptibility to cefiderocol, a novel siderophore cephalosporin.

UR - https://www.scopus.com/pages/publications/85090992686

UR - https://www.scopus.com/pages/publications/85090992686#tab=citedBy

U2 - 10.1093/cid/ciaa355

DO - 10.1093/cid/ciaa355

M3 - Article

C2 - 32236408

AN - SCOPUS:85090992686

SN - 1058-4838

VL - 71

SP - 2713

EP - 2716

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -

Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in enterobacter cloacae complex following exposure to cefepime

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this